与帕金森病相关的氨酸丰富的重复激酶2 (LRRK2) 的结构生物学
相关实验视频
Updated: Sep 19, 2025

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.7K
1Department of Cellular and Molecular Medicine, School of Medicine, University of California San Diego, La Jolla, California, USA; Department of Molecular Biology, School of Biological Sciences, University of California San Diego, La Jolla, California, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, Maryland, USA.
The Journal of biological chemistry
|June 16, 2025
概括
氨酸丰富的重复激酶2 (LRRK2) 是帕金森病 (PD) 治疗的关键标. 结构生物学的进步揭示了LRRK2在PD病变发生过程中的作用的功能性见解.
科学领域:
- 神经科学是一个神经科学.
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 与帕金森病 (PD) 病原发生有关.
- LRRK2已经成为PD的主要治疗点.
- 了解LRRK2结构对于开发有效的治疗方法至关重要.
研究的目的:
- 审查LRRK2结构生物学现状.
- 突出从LRRK2结构中获得的功能洞察力.
- 为研究人员和临床医生提供全面的概述.
主要方法:
- 对LRRK2结构研究的文献综述.
- 对已发表的LRRK2蛋白质结构进行分析.
- 整合结构数据与功能和遗传发现.
主要成果:
- 在阐明LRRK2结构方面取得了重大进展.
- 确定影响LRRK2活动的关键结构特征.
- 结构见解与PD相关突变的相关性.
结论:
- LRRK2的结构生物学已经迅速发展.
- 结构数据为PD提供了关键的功能洞察力.
- 持续的结构研究将加速LRRK2向的PD疗法.
相关概念视频
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Enzyme-linked Receptors
80.1K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.1K
Receptor Tyrosine Kinases
14.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.5K
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391

